GENFIT Share Price Deutsche Boerse AG
Stocks
XUP
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
07:01:23 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 14.06 EUR | -2.09% |
|
+8.15% | +168.06% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 721M 842M 675M 618M 1.16B 80.63B 1.17B 7.97B 3.11B 40.47B 3.16B 3.09B 134B | P/E 2026 * |
37.2x | P/E 2027 * | 95.8x |
|---|---|---|---|---|---|
| Enterprise Value | 670M 783M 627M 574M 1.08B 74.92B 1.09B 7.41B 2.89B 37.6B 2.94B 2.87B 124B | EV / Sales 2026 * |
6.69x | EV / Sales 2027 * | 5.28x |
| Free-Float |
86.89% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.09% | ||
| 1 week | +8.15% | ||
| Current month | +0.29% | ||
| 1 month | +10.36% | ||
| 3 months | +67.98% | ||
| 6 months | +72.83% | ||
| Current year | +168.06% |
| 1 week | 12.94 |  | 14.36 |
| 1 month | 12.72 | | 14.86 |
| Current year | 5.08 | | 14.86 |
| 1 year | 3.01 | | 14.86 |
| 3 years | 2.8 | | 14.86 |
| 5 years | 2.74 | | 14.86 |
| 10 years | 2.74 | | 33.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 15/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 21/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 26/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 15/06/2017 | |
| Director/Board Member | 54 | 14/09/1999 | |
| Director/Board Member | 58 | 15/06/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.09% | +8.15% | - | - | 824M | |
| +1.09% | +3.39% | +3.50% | +25.49% | 51.22B | |
| -1.07% | +3.69% | +479.26% | +607.16% | 45.38B | |
| +1.44% | +5.19% | +21.06% | +93.98% | 41.97B | |
| +1.47% | +7.58% | +35.29% | +21.42% | 42.15B | |
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | |
| -0.60% | +2.87% | - | - | 16.73B | |
| +1.32% | +6.67% | +33.29% | +148.62% | 17.1B | |
| +0.03% | +3.91% | +5.84% | +35.04% | 14.76B | |
| +1.28% | +4.95% | +84.98% | +48.41% | 13.91B | |
| Average | +0.19% | +3.19% | +85.08% | +128.34% | 30.58B | |
| Weighted average by Cap. | +0.47% | +3.13% | +103.29% | +150.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 117M 93.69M 85.78M 161M 11.2B 163M 1.11B 432M 5.62B 439M 430M 18.6B | 124M 145M 116M 106M 199M 13.87B 202M 1.37B 534M 6.96B 544M 532M 23.03B |
| Net income | 22.88M 26.72M 21.39M 19.59M 36.77M 2.56B 37.25M 253M 98.57M 1.28B 100M 98.12M 4.25B | 6.8M 7.94M 6.36M 5.82M 10.93M 760M 11.07M 75.17M 29.3M 382M 29.81M 29.16M 1.26B |
| Net Debt | -51.12M -59.69M -47.8M -43.76M -82.16M -5.71B -83.22M -565M -220M -2.87B -224M -219M -9.49B | -66.17M -77.28M -61.88M -56.65M -106M -7.4B -108M -732M -285M -3.71B -290M -284M -12.29B |
| Date | Price | Change |
|---|---|---|
| 21/08/26 | €14.06 | -2.09% |
| 20/08/26 | €14.36 | +5.28% |
| 19/08/26 | €13.64 | -0.73% |
| 18/08/26 | €13.74 | +6.18% |
| 17/08/26 | €12.94 | -2.85% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
Select your edition
All financial news and data tailored to specific country editions
